EIC Programs

ACG Webcast  |  EIC Toolkit  |  Medscape Test & Teach  |  Assessment Webinar
EIC - Journal Supplement

ACG Symposium Webcast

Educational Initiative on Constipation - Webcast
A 1 hour presentation from the ACG symposium
Focusing on IBS-C and Chronic Constipation
Presented by the Johns Hopkins University School of Medicine in collaboration with the American Academy of Nurse Practitioners
Supported by an educational grant from Sucampo Pharmaceuticals, Inc., and Takeda Pharmaceuticals North America, Inc.
Release date: April 1, 2009
Expiration date: March 31, 2010

Overview

The Educational Initiative on Constipation: Focusing on IBS-C and Chronic Constipation (EIC) will address knowledge gaps related to the identification, pathophysiology, diagnosis, management, and therapeutic strategies associated with IBS-C and chronic constipation. The Webcast is a taping from the satellite symposium that took place October 5th, 2008 in Orlando during the ACG Annual Meeting.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

This program has been approved for 1.0 contact hour(s) of continuing education by the American Academy of Nurse Practitioners. Program ID 0903141

The purpose of this program is to measurably improve the management of irritable bowel syndrome-constipation (IBS-C) by gastroenterologists, primary care physicians, nurse practitioners, and physician assistants who treat patients with chronic constipation and IBS-C.

Policy on Faculty and Provider Disclosure

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty or author reported the following.

Mark Donowitz, MD, reports receiving honoraria from Sucampo Pharmaceuticals, Inc; holding stock in Tranzmembrane, Inc (holder of NHE3 patent); and serving on the scientific advisory board for Institute for One World Health.

Henry Parkman, MD, reports receiving grants/research support from Medtronic, Inc, SmartPill Corporation, and Tranzyme Pharma Inc; serving as a consultant for SmartPill Corporation and Tranzyme Pharma Inc; and serving on the speakers' bureau for SmartPill Corporation.

Adil Bharucha, MD, reports having no financial or advisory relationships with corporate organizations related to this activity.

Satish Rao, MD, PhD, reports receiving grants/research support from SmartPill Corporation; serving as a consultant for Boehringer Ingelheim, Forest Laboratories, Inc, Proctor & Gamble, SmartPill Corporation, Takeda Pharmaceuticals North America, Inc; and serving on the speakers' bureau for AstraZeneca, Pharmaceuticals, Inc, and Takeda Pharmaceuticals North America, Inc.

Jonathan Kaunitz, MD, reports receiving grants/research support from Takeda Pharmaceuticals North America, Inc.

Off-Label Product Discussion

All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or products.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

In order to receive credit, participants must view the webcast and complete a post test and activity evaluation. A score of at least 70% is required to successfully complete the activity. If the post-test is passed, a certificate will be displayed on screen that participants can print and keep for their records.

Click here to view the webcast

Physicians: Click here to complete the CME post test and evaluation

Nurse Practitioners: Click here to complete the CE post test and evaluation

EIC Toolkit

The success or failure of education is based on the nature and quality of the didactic design and strategy, and on sound implementation practices. Ensuring that the education provided is integrated into ongoing patient care for the health care professional through an enabling activity, such as a toolkit, can enhance the effectiveness of the overall educational strategy. To do so, one has to consider that any such enabling tool is specific to the audience and the therapeutic area, is available to all participants, and is educationally consistent and synergistic with the overall learning objectives.

The EIC toolkit is intended to be a comprehensive set of analytical, diagnostic, and planning resources that will assist participants in reinforcing the overall goals, objectives, and learnings derived from the EIC activity. The goal of the toolkit is not to render any statements or conclusions surrounding clinical data, guidelines, or models, but rather to enlighten, reinforce, and provide easy access to information and best practices attained from the EIC activity.

Download the EIC Toolkit

Medscape Test & Teach

Educational Initiative on Constipation - Medscape Test & Teach
Focusing on IBS-C and Chronic Constipation
Presented by the Johns Hopkins University School of Medicine in collaboration with the American Academy of Nurse Practitioners

Supported by an educational grant from Sucampo Pharmaceuticals, Inc., and Takeda Pharmaceuticals North America, Inc.

Overview

The Educational Initiative on Constipation: Focusing on IBS-C and Chronic Constipation (EIC) will address knowledge gaps related to the identification, pathophysiology, diagnosis, management, and therapeutic strategies associated with IBS-C and chronic constipation. The Webinar is the first component of a large initiative offering an interactive learning format with integrated case studies, which will cover 4 main areas in which participants' educational needs have been identified:

• Update on the status of treating constipation management
• Pathophysiology, diagnosis, and management of patients with constipation (including quality-of-life issues)
• Maximizing therapeutic strategies in patients with constipation
• Role of multidisciplinary care in the treatment of patients with constipation

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.

This program has been approved for 1.0 contact hour(s) of continuing education by the American Academy of Nurse Practitioners. Program ID 0812592

Medscape's Test & Teach programming capitalizes on the keys to adult learning for medical professionals. The Test and Teach tactic tests the level of a clinician understanding before providing educational content, then educational content is provided to reinforce or educate. This Highly interactive patient case format is designed to engage and motivate the physician and tailor learning to current understanding. The Test and Teach tactic consists of a one--hour interactive CME patient case review, incorporating 10-15 questions followed by answers.

Click here to begin registration

Assessment Webinar

Educational Initiative on Constipation - On-Demand Webinar
Focusing on IBS-C and Chronic Constipation
Presented by the Johns Hopkins University School of Medicine

Supported by an educational grant from Sucampo Pharmaceuticals, Inc., and Takeda Pharmaceuticals North America, Inc.

Overview

The Educational Initiative on Constipation: Focusing on IBS-C and Chronic Constipation (EIC) will address knowledge gaps related to the identification, pathophysiology, diagnosis, management, and therapeutic strategies associated with IBS-C and chronic constipation. The Webinar is the first component of a large initiative offering an interactive learning format with integrated case studies, which will cover 4 main areas in which participants' educational needs have been identified:

• Update on the status of treating constipation management
• Pathophysiology, diagnosis, and management of patients with constipation (including quality-of-life issues)
• Maximizing therapeutic strategies in patients with constipation
• Role of multidisciplinary care in the treatment of patients with constipation

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Click here to begin registration

EIC - Journal Supplement

Focusing on IBS-C and Chronic Constipation
Presented by the Johns Hopkins University School of Medicine in collaboration with the American Academy of Nurse Practitioners

Supported by an educational grant from Sucampo Pharmaceuticals, Inc., and Takeda Pharmaceuticals North America, Inc.

Overview

The Educational Initiative on Constipation: Focusing on IBS-C and Chronic Constipation (EIC) will address knowledge gaps related to the identification, pathophysiology, diagnosis, management, and therapeutic strategies associated with IBS-C and chronic constipation. The Webinar is the first component of a large initiative offering an interactive learning format with integrated case studies, which will cover 4 main areas in which participants' educational needs have been identified:

• Update on the status of treating constipation management
• Pathophysiology, diagnosis, and management of patients with constipation (including quality-of-life issues)
• Maximizing therapeutic strategies in patients with constipation
• Role of multidisciplinary care in the treatment of patients with constipation

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

This program has been approved for 1.0 contact hour(s) of continuing education by the American Academy of Nurse Practitioners. Program ID 0812592

Journal Supplement "Constipation: A Significant Clinical Problem Affecting Quality of Life": This Special Report supplement is a 12-page journal sized monograph consisting of approximately 6,500 words with a 15-question multiple-choice self-assessment examination based on the content presented.

Click here to view